RxDoctor Payments Data
★ My doctorsLook up a doctor →

Ana Karabell

Pediatric Endocrinology · Memphis, TNNPI 1932361979

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,494 of the $13,529 with a category attached, or 62.8%. 54 manufacturers reported payments, led by Arbor Pharmaceuticals, Inc. at 30.5% of the total.

$13,529in general payments, 2019–2025

Across 419 payments — averaging $32.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arbor Pharmaceuticals, Inc.$4K
  • Insulet Corporation$2K
  • Novo Nordisk$1K
  • Medtronic$660
  • AbbVie$657
  • Lilly USA, LLC$533
  • plus $4K from 48 others
$81,552in research payments, 2019–2025

Across 9 payments — averaging $9061.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$82K

What the payments were for

  • Speaking & faculty fees$2,64020%
  • Travel & lodging$2,17116%
  • Food & beverage$8,49463%
  • Education$2242%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arbor Pharmaceuticals, Inc.15$4,129
Insulet Corporation47$1,768
Novo Nordisk65$1,353
Medtronic(2 entities)23$660
AbbVie45$657
Lilly USA, LLC23$533
Sanofi-aventis U.S. LLC17$339
Ascendis Pharma Endocrinology Inc14$324
Ascensia Diabetes Care US Inc.8$318
Azurity Pharmaceuticals, Inc.15$275
Xeris Pharmaceuticals, Inc.13$259
AstraZeneca12$216
BETA Bionics, Inc.3$200
Corcept Therapeutics6$200
Cequr Corporation3$173
Biomarin Pharmaceutical Inc.4$150
Kyowa Kirin, Inc.5$147
Sequel Med Tech, LLC6$143
Boehringer Ingelheim9$140
Neurocrine Biosciences, Inc.3$139
Amgen(2 entities)7$105
Merck7$100
Rhythm Pharmaceuticals, Inc.5$80
Ferring Pharmaceuticals Inc.6$76
IBSA Pharma Inc.5$74
Pfizer4$74
Bayer4$70
Companion Medical, Inc.2$58
Dexcom, Inc.3$56
Averitas Pharma Inc.3$54
Boston Scientific2$47
Nevro Corp.2$46
Amneal Pharmaceuticals LLC3$45
Shire North American Group Inc3$42
Soleno Therapeutics, Inc.2$38
Mannkind Corporation2$36
GRT US Holding, Inc.2$36
Endo USA, Inc.2$35
Recordati_rare_diseases_inc.2$35
Radius Health, Inc.2$34
Takeda Pharmaceuticals U.S.A., Inc.2$26
Antares Pharma, Inc.1$23
Optos, Inc.1$23
Chiesi USA, Inc.1$21
EUSA Pharma (US) LLC1$20
Eton Pharmaceuticals, Inc.1$20
Regeneron Healthcare Solutions, Inc.1$20
Amryt Pharma Holdings Ltd1$19
Tandem Diabetes Care, Inc.1$19
Amphastar Pharmaceuticals, Inc.1$17
Ipsen Biopharmaceuticals, Inc1$16
Abbott1$16
Ultragenyx Pharmaceutical Inc.1$13
Lifescan, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,529 in reported general payments places this provider in the 80th percentile of 37 pediatric endocrinology providers in Tennessee.

See all pediatric endocrinology providers in Tennessee →

Other pediatric endocrinology in Memphis

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →